https://www.worldpharmatoday.com/clinical-trails/abbvie-provides-update-on-phase-3-study-of-ibrutinib-in-blood-cancer-diffuse-large-b-cell-lymphoma-and-ongoing-ibrutinib-clinical-program/ Magazine for the C-level Pharma Executives Mon, 16 Jul 2018 06:09:31 +0000 hourly 1 https://wordpress.org/?v=6.9.4